Why Whole Foods is Hot
Health Care: Drugs
AVEO Pharmaceuticals Inc. (AVEO: NASDAQ)
$2.66 -0.24 | -8.28%
05/22/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -114.39M | 30.65M | -58.79M | -44.09M |
| Operating Gains/Losses | 42.00K | 35.00K | 1.00K | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -13.44M | -6.82M | 96.00K | 1.59M |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | -144.00K | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 1.72M | -343.00K | 1.76M | 3.64M |
| (Decrease) Increase In Other Current Liabilities | 5.25M | 4.17M | 2.56M | 25.80M |
| (Increase) Decrease In Other Working Capital | 5.13M | -11.89M | -410.00K | -1.82M |
| Other Non-Cash Items | 8.39M | 6.55M | 4.81M | 3.41M |
| Net Cash From Continuing Operations | -105.73M | 26.45M | -51.82M | -9.97M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -105.73M | 26.45M | -51.82M | -9.97M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 339.78M | 234.80M | 78.89M | 41.08M |
| Purchases of Property, Plant & Equipment | -9.95M | -2.63M | -1.69M | -1.73M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -194.58M | -376.27M | -167.71M | -35.93M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 135.25M | -144.10M | -90.51M | 3.41M |
| Issuance of Debt | 3.67M | 0.00 | 7.56M | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 1.64M | 115.37M | 138.56M | 33.02M |
| Repayment of Long-Term Debt | -2.17M | 0.00 | -3.28M | -1.99M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 3.14M | 115.37M | 142.83M | 31.03M |
| Effect of Exchange Rate Changes | -26.00K | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 32.63M | -2.28M | 501.00K | 24.48M |
Portfolios with AVEO
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ProSeth Klarman - Baupost Group
- Contributor7 Cancer Drug Stocks to Kno...
- ContributorBreakout Stocks Of The Week...
- ContributorHot Biotech Trades for Seco...
Latest AVEO Headlines from TheStreet
- 2013 FDA Drug Approval Calendar 05.21.13 | 07:05 am
- Aveo Screwed Up But Its Kidney Cancer Drug Is Real 05.15.13 | 08:05 am
- 3 Health Care Stocks Under $10 to Watch 05.09.13 | 09:05 pm
- Bubble Fears Amid Relentless Market Climb 05.06.13 | 02:05 pm
- Fire Aveo's CEO for Incompetence and Arrogance Rivaling ImClone's Sam Waksal 05.06.13 | 12:05 pm
- Leaders of TheStreet's Drug Approval Contest 05.06.13 | 09:05 am
- Stock Futures Eye Rebound on ECB Stimulus, U.S. Data 05.02.13 | 08:05 am
- Aveo, Delcath FDA Panel Live Blog 05.02.13 | 07:05 am
- Why Aveo's Tivozanib Should Win FDA Approval 05.02.13 | 06:05 am
- AVEO Pharmaceuticals Enters Oversold Territory (AVEO) 04.30.13 | 12:04 pm
Press Releases for AVEO
- Aveo Pharmaceuticals, Inc. Sued By Investor - PR Newswire 05.17.13 | 01:05 pm
- The Law Offices Of Marc S. Henzel Announces Class Action Lawsuit Against Aveo Pharmaceuticals, Inc. And Certain Officers -- (Nasdaq: AVEO) Was Filed On Behalf Of Stockholders - PR Newswire 05.14.13 | 09:05 pm
- Bernstein Liebhard LLP Announces That A Securities Class Action Has Been Filed Against Aveo Pharmaceutical, Inc. - PR Newswire 05.10.13 | 03:05 pm
- Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Aveo Pharmaceuticals, Inc. - PR Newswire 05.03.13 | 08:05 am
- AVEO Oncology To Present At The Barclays Global Healthcare Conference - Business Wire 03.06.13 | 06:03 am
- AVEO And Astellas Announce FDA Advisory Committee To Review Tivozanib For The Treatment Of Advanced Renal Cell Carcinoma - Business Wire 02.27.13 | 06:02 am
- AVEO Oncology To Present At The 2013 RBC Capital Markets’ Healthcare Conference - Business Wire 02.20.13 | 06:02 am
- AVEO And Astellas Report Final Overall Survival Results From TIVO-1 - Business Wire 02.12.13 | 06:02 pm
- AVEO Oncology Announces Timing For Fourth Quarter And Year-End 2012 Financial Results Conference Call - Business Wire 01.31.13 | 06:01 am
- AVEO And Astellas Announce Presentations Of Tivozanib Clinical Data At 2013 ASCO Genitourinary Cancers Symposium - Business Wire 01.29.13 | 06:01 am
Partner Headlines for AVEO
- UPDATE: Canaccord Genuity Downgrades AVEO Pharmaceuticals to Hold Following ODAC Meeting - Benzinga 05.03.13 | 09:05 am
- Pre-Market Most Active for Apr 30, 2013 : SIRI, MTU, SMFG, PFE, DCM, NTT, STM, NUAN, VOD, ANAD, AVEO, BBRY - NASDAQ 04.30.13 | 12:04 pm
- AVEO Pharmaceuticals Earnings: Here’s Why Shares are Down Now - Wall St. Cheat Sheet 04.29.13 | 10:04 am
- Thursday's BioPharma Trade Movers - Seeking Alpha 04.18.13 | 09:04 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 10.23.12 | 09:10 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 10.17.12 | 09:10 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 10.10.12 | 09:10 am
- Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3 - Seeking Alpha 05.25.12 | 08:05 pm
- 4 Compelling Alternatives To Vertex Pharma - Seeking Alpha 02.23.12 | 08:02 am
- 5 Stocks That Could Be Takeover Targets - Seeking Alpha 02.01.12 | 08:02 am
